Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Narrow Complex Tachcardia (QRS < 0.12)

 

History:

 

  • Medications
    • Aminophylline
    • Diet pills
    • Thyroid supplements
    • Decongestants
    • Digoxin
    • Diet (caffeine/chocolate)
    • Drugs (nicotine/cocaine)
  • Past medical history
  • History of palpitation/heart racing
  • Syncope/near syncope

 

Significant findings:

 

  • Heart rate >150
  • Chest pain
  • Systolic BP < 90
  • CHF
  • Dizziness
  • SOB
  • Diaphoresis
  • AMS
  • If QRS >0.12 or history of WPW, go to Sustained V-Tach Protocol
  • Potential presenting rhythm:
    • Atrial/sinus tachycardia
    • Atrial fibrillation/flutter
    • Multifocal atrial tachycardia

 

Differential:

 

  • Hypoxia
  • Fever
  • Sepsis
  • Dehydration
  • Sick sinus syndrome
  • Myocardial infarction
  • Electrolyte imbalance
  • Exertion/pain/emotional stress
  • Hypovolemia/anemia
  • Drugs/medications (see History)
  • Hyperthyroidism
  • Pulmonary embolus
  • Heart disease (WPW, valvular)

 

Treatment:

 

  • Oxygen
  • 12-Lead EKG
  • Initiate IV of Normal Saline (INT is not acceptable)
  • Attempt valsalva maneuver

 

Stable Tachycardia (QRS < 0.12) ?

 

  • No

 

See V-Tach Protocol

 

  • Yes

 

Regular ?

 

  • Yes

 

 

Improving ?

 

  • Yes

 

    • Notify receiving facility or contact Medical Control

 

  • No

 

 

 

    • if Diltiazem is unavailable consider Metoproplol 5 mg IV/IO slow push; may repeat a 2nd dose of 5 mg; max total dose 10 mg.

 

Stable Irregular Tachycardia ?

 

  • Yes

 

 

 

    • if Diltiazem is unavailable consider Metoproplol 5 mg IV/IO slow push; may repeat a 2nd dose of 5 mg; max total dose 10 mg.

 

    • Notify receiving facility or contact Medical Control

 

Unstable Tachycardia (QRS <0.12) ?

 

  • Yes

 

 

  • Synchronized Cardioversion

 

    • Cardiovert (synchronized) 100 joules
    • Cardiovert (synchronized) 200 joules
    • Cardiovert (synchronized) 300 joules
    • Cardiovert (synchronized) 360 joules

 

 

    • Notify receiving facility or contact Medical Control

 

PEARLS:

 

  • Symptomatic tachycardia usually occurs at rates of 120-150 and are typically greater than or equal to 150 beats per minute. Symptomatic patients with heart rates less than 150 likely have impaired cardiac function such as CHF.
  • Typical sinus tachycardia is in the range of 100 to (220 minus patient's age) beats per minute.
  • Serious signs/symptoms:
    • hypotension,
    • acutely altered mental status,
    • signs of shock/poor perfusion,
    • chest pain with evidence of STEMI or
    • T- wave inversions or depressions,
    • acute CHF.
  • If the patient has a history of WPW or 12-Lead EKG reveals WPW, DO NOT administer a calcium channel blocker (e.g., Diltiazem (Cardizem)) or a beta blocker.
  • Avoid carotid sinus massage in patients over 50 years old or with a history of prior neurological event.
  • For A-fib/A-flutter, consider administering Diltiazem (Cardizem) prior to administration of Adenosine (Adenocard).
  • For conscious sedation, see Sedation/Anxiety protocol. Dose should be titrated to provide comfort without causing respiratory failure. Be sure to monitor patient's breathing/ventilations, blood pressure and O2 saturation.
  • Document all rhythm changes and therapeutic interventions with monitor strips.